Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.

Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

erschienen in

Verlag

Geographic terms

Sprache

Datenbank

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 25 von 190, Suchdauer: 0.71s

12 3 4 5 6 7 8 weiter »

1
Impact of the tumor immune contexture in microsatellite-stable metastatic colorectal cancer treated with avelumab, cetuximab, and irinotecan

von Huyghe, Nicolas ; Benidovskaya, Elena ; Masoodi, Tariq ; et al.

In Cell Reports Medicine 15 July 2025 6(7)
- View full text via DOI
Merkliste

2
Patient and physician expectations regarding disease and treatment of advanced HCC: The prospective PERCEPTION1 study

von Nault, Jean-Charles ; Sritharan, Nanthara ; Verset, Gontran ; et al.

In JHEP Reports November 2024 6(11)
- View full text via DOI
Merkliste

3
120P Avelumab (AVE), cetuximab (CET) and irinotecan (IRI) for treatment refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Characterization of the circulating immune response in the AVETUXIRI phase II trial

von Benidovskaya, Elena ; Huyghe, Nicolas ; Carrasco, Javier ; et al.

Annals of Oncology, Vol. 35, no.Suppl 1, p. S56 (2024)
- View full text via BASE
Merkliste

4
599P R-IMMUNE: A phase Ib/II study to evaluate safety and efficacy of atezolizumab combined with radio-chemotherapy in a preoperative setting for patients with locally advanced rectal cancer (LARC)

von Carrasco, Javier ; Beniuga, Gabriela ; Mourin, Anne ; et al.

Annals of Oncology, Vol. 34, no.Suppl 1, p. S432 (2023)

Schlagworte: Oncology; Hematology
- View full text via BASE
Merkliste

5
2237P Avelumab (AVE), cetuximab (CET) and irinotecan (IRI) for treatment refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Translational analyses of the AVETUXIRI phase II trial

von Huyghe, Nicolas ; Benidovskaya, Elena ; Masoodi, Tariq ; et al.

Annals of Oncology, Vol. 34, no.Suppl 1, p. S1152 (2023)

Schlagworte: Oncology; Hematology
- View full text via BASE
Merkliste

6
635P Avelumab (AVE) combined with cetuximab (CET) and irinotecan (IRI) for the treatment of refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC): The AVETUXIRI phase II study

von Van den Eynde, Marc ; Huyghe, Nicolas ; Sinapi, Isabelle ; et al.

Annals of Oncology, Vol. 34, no.Suppl 1, p. S450 (2023)

Schlagworte: Oncology; Hematology
- View full text via BASE
Merkliste

7
Homogeneity of pathological response (PR) and histopathological growth pattern (HGP) in resected colorectal liver metastases (CRLM) are associated with favorable survival outcome after surgery.

von Baldin, Paméla ; Beniuga, Gabriella ; Carrasco, Javier ; et al.

Journal of Clinical Oncology, Vol. 40, no.16_suppl, p. 3596-3596 (2022)

Schlagworte: Cancer Research; Oncology
- View full text via BASE
Merkliste

8
Interim analysis of the phase II AVETUXIRI trial: Avelumab combined with cetuximab and irinotecan for treatment of refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC).

von Huyghe, Nicolas ; De Cuyper, Astrid ; Sinapi, Isabelle ; et al.

Journal of Clinical Oncology, Vol. 40, no.16_suppl, p. 3595-3595 (2022)

Schlagworte: Cancer Research; Oncology
- View full text via BASE
Merkliste

9
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

von Kelley, Robin Kate ; Ueno, Makoto ; Yoo, Changhoon ; et al.

ISSN: 0140-6736.

Schlagworte: [SDV.CAN]Life Sciences [q-bio]/Cancer
- View full text via BASE
Merkliste

10
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial

von Luft, Alexander V. ; Karaseva, Nina A. ; Kowalyszyn, Rubén Dario ; et al.

In The Lancet Oncology March 2019 20(3):420-435
- View full text via DOI
Merkliste

11
Interim analysis of the AVETUXIRI Trial: Avelumab combined with cetuximab and irinotecan for treatment of refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC)—A proof of concept, open-label, nonrandomized phase IIa study.

von Van den Eynde, Marc ; Huyghe, Nicolas ; De Cuyper, Astrid ; et al.

Journal of Clinical Oncology, Vol. 39, no.3_suppl, p. 80-80 (2021)

Schlagworte: Cancer Research; Oncology
- View full text via BASE
Merkliste

12
Randomized Phase 2 Study Comparing Pathological Responses of Resected Colorectal Cancer Metastases after Bevacizumab with mFOLFOX6 or FOLFIRI (BEV-ONCO Trial)

von Baldin, Paméla ; Carrasco, Javier ; Beniuga, Gabriela ; et al.

Cancers, Vol. 14, no. 5, p. 1183 [1-16] (2022)

Schlagworte: Cancer Research; Oncology; bevacizumab; chemotherapy; colorectal liver metastases; pathological response; histological growth pattern; tumoral homogeneity
- View full text via BASE
Merkliste

13
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: a 13 years-retrospective monocentric study.

von Livin, Marie ; Léonard, Daniel ; Bachmann, Radu ; et al.

Acta gastro-enterologica Belgica, Vol. 85, no. 4, p. 573-579 (2022)

Schlagworte: Humans; Peritoneal Neoplasms; Retrospective Studies; Hyperthermic Intraperitoneal Chemotherapy; Combined Modality Therapy; Colorectal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Cytoreduction Surgical Procedures; Percutaneous Coronary Intervention; Hyperthermia; Induced; Liver Neoplasms; Survival Rate; cytoreductive surgery; peritoneal carcinomatosis
- View full text via BASE
Merkliste

14
Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study.

von van Marcke de Lummen, Cédric ; Honoré, Natasha ; van der Elst, Athénaïs ; et al.

BMC cancer, Vol. 21, no.1, p. 578 [1-12] (2021)

Schlagworte: Aged; Ambulatory Care; Belgium; COVID-19; Cancer Care Facilities; Cohort Studies; Female; Health Personnel; Humans; Male; Middle Aged; Neoplasms; Risk Factors; SARS-CoV-2; Ambulatory; Non-severe COVID-19; Safety; Systemic anti-cancer treatment
- View full text via BASE
Merkliste

15
Patient and physician expectations regarding disease and treatment of advanced HCC: The prospective PERCEPTION1 study

von Nault, Jean Charles ; Sritharan, Nanthara ; Verset, Gontran ; et al.

JHEP Reports, 6 (11

Schlagworte: Médecine pathologie humaine; hepatocellular carcinoma; immunotherapy; life expectancy; perception; systemic treatment; info:eu-repo/semantics/article; info:ulb-repo/semantics/articlePeerReview; info:ulb-repo/semantics/openurl/article
- Zum Volltext über OAIster
Merkliste

16
120P Avelumab (AVE), cetuximab (CET) and irinotecan (IRI) for treatment refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Characterization of the circulating immune response in the AVETUXIRI phase II trial

von UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie ; UCL - (SLuc) Service d'oncologie médicale ; Benidovskaya, Elena ; et al.

Annals of Oncology, Vol. 35, no.Suppl 1, p. S56 (2024)

Schlagworte: info:eu-repo/semantics/conferenceObject
- Zum Volltext über OAIster
Merkliste

17
Efficacy and safety of short-course radiotherapy versus total neoadjuvant therapy in older rectal cancer patients: a randomised pragmatic trial (SHAPERS)

von Saúde Conde, Rita ; Vandamme, T. ; De Backer, M. ; et al.

ESMO Gastrointestinal Oncology, 4

Schlagworte: Cancérologie; Imagerie médicale, radiologie, tomographie; Gastro-entérologie; info:eu-repo/semantics/article; info:ulb-repo/semantics/articlePeerReview; info:ulb-repo/semantics/openurl/article
- Zum Volltext über OAIster
Merkliste

18
599P R-IMMUNE: A phase Ib/II study to evaluate safety and efficacy of atezolizumab combined with radio-chemotherapy in a preoperative setting for patients with locally advanced rectal cancer (LARC)

von UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie ; UCL - SSS/IREC/MORF - Pôle de Morphologie ; UCL - (SLuc) Service d'anatomie pathologique ; et al.

Annals of Oncology, Vol. 34, no.Suppl 1, p. S432 (2023)

Schlagworte: Oncology; Hematology; info:eu-repo/semantics/conferenceObject
- Zum Volltext über OAIster
Merkliste

19
635P Avelumab (AVE) combined with cetuximab (CET) and irinotecan (IRI) for the treatment of refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC): The AVETUXIRI phase II study

von UCL - SSS/IONS/NEUR - Clinical Neuroscience ; UCL - SSS/IREC/IMAG - Pôle d'imagerie médicale ; UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie ; et al.

Annals of Oncology, Vol. 34, no.Suppl 1, p. S450 (2023)

Schlagworte: Oncology; Hematology; info:eu-repo/semantics/conferenceObject
- Zum Volltext über OAIster
Merkliste

20
Tumor lysis syndrome following trastuzumab and pertuzumab for metastatic breast cancer: a case report.

von Baudon, Céline ; Duhoux, François ; Sinapi, Isabelle ; et al.

Journal of Medical Case Reports, Vol. 10, no.1, p. 178 (2016)
- View full text via BASE
Merkliste

21
2237P Avelumab (AVE), cetuximab (CET) and irinotecan (IRI) for treatment refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Translational analyses of the AVETUXIRI phase II trial

von UCL - SSS/IONS/NEUR - Clinical Neuroscience ; UCL - SSS/IREC/IMAG - Pôle d'imagerie médicale ; UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie ; et al.

Annals of Oncology, Vol. 34, no.Suppl 1, p. S1152 (2023)

Schlagworte: Oncology; Hematology; info:eu-repo/semantics/conferenceObject
- Zum Volltext über OAIster
Merkliste

22
Gemcitabine and oxaliplatin chemotherapy for advanced hepatocellular carcinoma after failure of anti-angiogenic therapies

von Patrikidou, Anna ; Sinapi, Isabelle ; Regnault, Hélène ; et al.

Investigational New Drugs: The Journal of New Anticancer Agents. October 2014 32(5):1028-1035
- Zum Volltext (via ReDI)
Merkliste

23
Posters

von Kraja, Bledar ; Pupuleku, Fatjona ; Harizi, Ilda ; et al.

Schlagworte: abstracts
- View full text via BASE
Merkliste

24
Interim analysis of the phase II AVETUXIRI trial: Avelumab combined with cetuximab and irinotecan for treatment of refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC).

von UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie ; UCL - SSS/IREC - Institut de recherche expérimentale et clinique ; UCL - (SLuc) Service d'hépato-gastro-entérologie ; et al.

Journal of Clinical Oncology, Vol. 40, no.16_suppl, p. 3595-3595 (2022)

Schlagworte: Cancer Research; Oncology; info:eu-repo/semantics/conferenceObject
- Zum Volltext über OAIster
Merkliste

25
Homogeneity of pathological response (PR) and histopathological growth pattern (HGP) in resected colorectal liver metastases (CRLM) are associated with favorable survival outcome after surgery.

von UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie ; UCL - (SLuc) Service d'hépato-gastro-entérologie ; UCL - (SLuc) Service d'oncologie médicale ; et al.

Journal of Clinical Oncology, Vol. 40, no.16_suppl, p. 3596-3596 (2022)

Schlagworte: Cancer Research; Oncology; info:eu-repo/semantics/conferenceObject
- Zum Volltext über OAIster
Merkliste

12 3 4 5 6 7 8 weiter »

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag